HI
GSK icon

Human Investing’s GSK GSK Stock Holding History

Human Investing’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,389
Closed -$232K – 98
2023
Q3 		$232K Sell
6,389
-575
-8% -$20.4K 0.05% 91
2023
Q2 		$248K Sell
6,964
-935
-12% -$33.5K 0.06% 86
2023
Q1 		$281K Sell
7,899
-25
-0.3% -$875 0.07% 83
2022
Q4 		$278K Sell
7,924
-2,103
-21% -$70K 0.07% 92
2022
Q3 		$295K Sell
10,027
-4,179
-29% -$158K 0.08% 92
2022
Q2 		$773K Sell
14,206
-240
-2% -$13.2K 0.19% 72
2022
Q1 		$787K Sell
14,446
-3,794
-21% -$206K 0.17% 81
2021
Q4 		$1M Sell
18,240
-158
-0.9% -$8.22K 0.24% 61
2021
Q3 		$879K Sell
18,398
-117
-0.6% -$5.88K 0.21% 87
2021
Q2 		$922K Sell
18,515
-275
-1% -$13.2K 0.22% 86
2021
Q1 		$838K Sell
18,790
-740
-4% -$33.6K 0.21% 90
2020
Q4 		$898K Sell
19,530
-737
-4% -$33.9K 0.25% 85
2020
Q3 		$954K Buy
20,267
+1,818
+10% +$91.1K 0.31% 81
2020
Q2 		$941K Sell
18,449
-215
-1% -$11K 0.33% 78
2020
Q1 		$884K Sell
18,664
-2,726
-13% -$145K 0.38% 74
2019
Q4 		$1.26M Sell
21,390
-142
-0.7% -$7.9K 0.41% 69
2019
Q3 		$1.15M Sell
21,532
-514
-2% -$26.4K 0.41% 72
2019
Q2 		$1.1M Sell
22,046
-377
-2% -$18.9K 0.4% 75
2019
Q1 		$1.17M Buy
22,423
+1,049
+5% +$52.4K 0.44% 73
2018
Q4 		$1.02M Buy
+21,374
New +$1.05M 0.43% 75

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Human Investing's GSK Position: Q4 2023 in Review

Human Investing sold out of GSK (GSK) in Q4 2023, closing a stake of 6,389 shares — an estimated $232K sold.

Human Investing first reported a position in GSK in Q4 2018 and held it in 20 quarters. The position peaked at $1.26M in Q4 2019. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Human Investing reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Human Investing sold 6,389 GSK shares in Q4 2023, an estimated $232K.
  • Human Investing first reported a position in GSK in Q4 2018 and held it in 20 quarters.
  • Human Investing's GSK position peaked at $1.26M in Q4 2019.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Human Investing's 13F filing for Q4 2023, filed 12 Feb 2024.